These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20827193)

  • 21. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal consequences of obesity.
    Naumnik B; Myśliwiec M
    Med Sci Monit; 2010 Aug; 16(8):RA163-70. PubMed ID: 20671624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progression factors for chronic kidney disease. Secondary prevention].
    García de Vinuesa S
    Nefrologia; 2008; 28 Suppl 3():17-21. PubMed ID: 19018733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.
    Navarro-Díaz M; Serra A; Romero R; Bonet J; Bayés B; Homs M; Pérez N; Bonal J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S213-7. PubMed ID: 17130264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Obesity and chronic kidney disease].
    Bondar' IA; Klimontov VV; Simakova AI
    Ter Arkh; 2011; 83(6):66-70. PubMed ID: 21786579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.
    Wuerzner G; Pruijm M; Maillard M; Bovet P; Renaud C; Burnier M; Bochud M
    Am J Kidney Dis; 2010 Aug; 56(2):303-12. PubMed ID: 20538392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity and chronic kidney disease.
    Kopple JD
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S29-30. PubMed ID: 20797567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension and kidney disease in Asia.
    Jafar TH
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):291-5. PubMed ID: 16609297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
    Poli D; Antonucci E; Zanazzi M; Grifoni E; Testa S; Ageno W; Palareti G
    Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.
    Jones C; Roderick P; Harris S; Rogerson M
    Nephrol Dial Transplant; 2006 Aug; 21(8):2133-43. PubMed ID: 16644779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
    Iseki K
    J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease.
    Ovbiagele B; Sanossian N; Liebeskind DS; Kim D; Ali LK; Pineda S; Saver JL
    Cerebrovasc Dis; 2009; 28(6):582-8. PubMed ID: 19844098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5.
    Serrano A; Huang J; Ghossein C; Nishi L; Gangavathi A; Madhan V; Ramadugu P; Ahya SN; Paparello J; Khosla N; Schlueter W; Batlle D
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):105-12. PubMed ID: 17200050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of weight loss in obesity and chronic kidney disease.
    Morales E; Praga M
    Curr Hypertens Rep; 2012 Apr; 14(2):170-6. PubMed ID: 22258314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the glomerular filtration rate in obese adult patients for drug dosing.
    Pai MP
    Adv Chronic Kidney Dis; 2010 Sep; 17(5):e53-62. PubMed ID: 20727504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interpreting different measures of glomerular filtration rate in obesity and weight loss: pitfalls for the clinician.
    Jesudason DR; Clifton P
    Int J Obes (Lond); 2012 Nov; 36(11):1421-7. PubMed ID: 22184061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
    Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
    Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.